Emergentec Biodevelopment GmbH

Emergentec Biodevelopment GmbH is an SME in Wien, Austria that has taken part in 8 EU-funded projects since 2008, receiving €3.7M in EU funding and leading 1 as coordinator.

EU funding received€3.7M
EU projects8
As coordinator1
Running now0
First EU project2008
Latest project2020
CountryAustria
EU registration (PIC)999703050
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Emergentec Biodevelopment GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.5M · 5 projects
  • Horizon 2020€1.2M · 3 projects

Projects

8 EU-funded projects, newest first. Emergentec Biodevelopment GmbH led 1 of them as coordinator. Each links to the official record.

  • DC-renPartner

    Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren)

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €899ktheir share
  • DISCOvERIEPartner

    Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe

    Horizon 2020 · 2020–2025 · Project on CORDIS ↗

    €268ktheir share
  • PRETREATPartner

    PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

  • DIPROMONPartner

    Multimodular biomarker analysis workflow for diagnosis, prognosis and monitoring of drug treatment response in bladder cancer""

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €371ktheir share
  • OCTIPSPartner

    Ovarian Cancer Therapy – Innovative Models Prolong Survival

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €231ktheir share
  • EU-MASCARAPartner

    Markers for Sub-Clinical Cardiovascular Risk Assessemnt

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €222ktheir share
  • SYSKIDCoordinator

    Systems biology towards novel chronic kidney disease diagnosis and treatment

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €816ktheir share
  • PREDICT-IVPartner

    Profiling the toxicity of new drugs: a non animal-based approach integrating toxicodynamics and biokinetics

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €875ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • bladder cancer
  • cardiovascular diseases
  • cell biology
  • diabetes
  • drug discovery
  • drug safety
  • eHealth
  • enzymes
  • epidemiology
  • genomes
  • kidney diseases
  • mortality
  • oncology
  • pathology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime